Next Article in Journal
Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study
Next Article in Special Issue
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C44Mab-3 for Multiple Applications against Pancreatic Carcinomas
Previous Article in Journal
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
 
 
Review

Article Versions Notes

Antibodies 2023, 12(1), 21; https://doi.org/10.3390/antib12010021
Action Date Notes Link
article xml file uploaded 3 March 2023 07:54 CET Original file -
article xml uploaded. 3 March 2023 07:54 CET Update https://www.mdpi.com/2073-4468/12/1/21/xml
article pdf uploaded. 3 March 2023 07:54 CET Version of Record https://www.mdpi.com/2073-4468/12/1/21/pdf
article html file updated 3 March 2023 07:55 CET Original file -
article html file updated 20 March 2023 20:28 CET Update https://www.mdpi.com/2073-4468/12/1/21/html
Back to TopTop